SCHEMBL16095192

SCHEMBL16095192

N#Cc1ccnc(-c2nc[nH]c2C(c2ccc(Cl)cc2)C2CC2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 2/20 0.38
▸ MAP3K12 Q12852 1/20 0.33
▸ PSD A5PKW4 2/20 0.32
▸ NPY5R Q15761 3/20 0.32
▸ KCNH2 Q12809 2/20 0.32
▸ S1PR1 P21453 1/20 0.31
▸ S1PR3 Q99500 1/20 0.31
▸ USP30 Q70CQ3 2/20 0.31
▸ MALT1 Q9UDY8 1/20 0.31
▸ PANK3 Q9H999 1/20 0.31
▸ SLC6A2 P23975 1/20 0.30
▸ SLC6A4 P31645 1/20 0.30
▸ SLC6A3 Q01959 1/20 0.30
▸ AKT1 P31749 1/20 0.30
▸ NOS3 P29474 1/20 0.30
▸ NOS1 P29475 1/20 0.30
▸ NOS2 P35228 1/20 0.30
▸ EIF4A3 P38919 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ TYK2 P29597 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16094450 0.81 NPY5R (0.34) MGLLMAP3K12NPY5RKCNH2USP30
SCHEMBL16095507 0.80 KDM4C (0.46) —
SCHEMBL16095318 0.76 KDM4C (0.52) —
SCHEMBL16100266 0.71 IDH1 (0.36) NPY5RKCNH2EIF4A3LMNA
SCHEMBL16095604 0.70 KDM4C (0.36) NPY5RKCNH2TYK2
SCHEMBL16095225 0.70 NPY5R (0.41) NPY5RKCNH2
SCHEMBL16095272 0.70 NPY5R (0.35) NPY5RKCNH2
SCHEMBL16095178 0.69 KDM4C (0.36) KCNH2S1PR1S1PR3SLC6A2SLC6A4
SCHEMBL16033875 0.68 NPY5R (0.38) NPY5RKCNH2USP30
SCHEMBL17604548 0.65 NPY5R (0.38) NPY5RKCNH2USP30GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2969007-A1 HISTONE DEMETHYLASE INHIBITORS Quanticel Pharmaceuticals Inc (US) 2016-01-20 — — EP disclosed
WO-2014151945-A1 HISTONE DEMETHYLASE INHIBITORS Quanticel Pharmaceuticals, Inc. (US) 2014-09-25 — — WO disclosed
Send feedback